ABC urgently needs more cash, says Kim Williams
In an address to the Melbourne Press Club to mark his one-year anniversary as chairman, Kim Williams bemoaned the fact that the ABC’s funding has dwindled over the past decade.
Our Team
Latest
ASX edges higher; tariffs wait keeps investors cautious
Star pins hopes on Bally’s as refinancing talks with Salter fail. MinRes, founder Chris Ellison slapped with class action. Zip loses in court. US Fed official worried about tariff policy ‘fog’.
RBA holds rates ahead of Trump’s day of reckoning
RBA board holds cash rate at 4.1pc, ‘did not explicitly discuss rate cuts’ says Bullock as focus shifts to May. ASX lifts 1pc. Housing groups welcome Coalition promise to drop mortgage buffer.
$42bn loss: ASX 200 smashed on tariff fears
Markets brace for Trump’s ‘Liberation Day’. US recession probability doubles: GS. Nine, Domain fall amid CoStar talks. RBA, ASIC salvo weighs on bourse operator ASX.
‘Unfair’: Vic family business to lose $2m-plus on Trump call
The real cost of tariffs are coming to light, as businesses such as Richard Davies’ face uncertain futures amid escalating trade tensions.
Your guide on what to watch this weekend
A horror show without the jump scares, this Netflix sensation hammers home the dangers of our connected world’s dark corners.
ASX 200 mostly erases gain as ANZ dives; Gold Road top gainer
WA miner Gold Road hits record amid standoff with rejected suitor, partner Gold Fields. Regal in recovery mode as Opthea questions remain. James Hardie stays in the red after analyst ratings changes. Budget to reveal worsening debt outlook.
Sit down and binge the best show of the year – so far
Summer is done. Stay inside this weekend and check out these television selections – including a medical drama which does the simple things really, really well.
ASX 200’s best day in six weeks
AUD down on 53,000 fewer jobs in Feb. Judo dives as Bain, GIC offload stake. Rinehart-backed Arafura’s best day in almost a year. Red flag raised after $20m withdrawal by Star patrons. Nanosonics is top mid-cap gainer after US FDA tick.
ASX 200 back in the red; MinRes down
MinRes faces more bumps on Onslow haul road. Myer’s challenges continue as costs rise. ‘Value destructive’: Rio dismisses unification push. Hanwha ‘wildly mistaken’ on new move: Austal chair.
Original URL: https://www.theaustralian.com.au/author/joseph-carbone/page/5